Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation.

Autor: Soueges, Sarah, Triffault-Fillit, Claire, Roux, Sandrine, Labussière-Wallet, Hélène, Lebeaux, David, Dumitrescu, Oana, Morelec, Isabelle, Hodille, Elisabeth, Ader, Florence, On behalf of the Lyon HEMINF study group, Ader, F., Alcazer, V., Bachy, E., Balsat, M., Barraco, F., Boccard, M., Conrad, A., Ducastelle-Leprêtre, S., Dumitrescu, O., Dupont, D.
Předmět:
Zdroj: European Journal of Clinical Microbiology & Infectious Diseases; Sep2021, Vol. 40 Issue 9, p2033-2036, 4p
Abstrakt: Nocardiosis is a life-threatening opportunistic infection in immunocompromised patients. Herein, we present successful adjunctive use of liposomal nebulized amikacin and tedizolid in a recipient of allogeneic hematopoietic stem cell transplantation infected with Nocardia nova complex who presented multiple complications to conventional therapeutic options. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: